Keywords: tysabri, ph, iii, meets, endpoint, crohn, ireland

Tysabri Ph III meets endpoint in Crohn's

Article | 11 July 2005

Print This

Ireland's Elan and US partner Biogen Idec have reported encouraging Phase III clinical trial results in the treatment of Crohn's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in